綠盟科技(300369.SZ):啟迪科服擬轉讓4000萬股予天津金禾擬設立並管理的建銀基金
格隆匯9月22日丨綠盟科技(300369.SZ)公佈,2021年9月22日,啟迪科服與天津建銀國際金禾股權投資管理有限公司(“天津金禾”或受讓方)簽訂的《股份轉讓協議》,啟迪科服向天津金禾擬設立並管理的私募投資基金(“建銀基金”)轉讓所持有的公司4000萬股股份,轉讓價格為人民幣15.3元/股,交易金額共計人民幣6.12億元。
交易完成後,建銀基金持有公司4000萬股股份,佔公司總股本(為剔除公司回購賬户股份後的總股本)的 5.1109%;啟迪科服持有公司股份256.5553萬股,佔公司總股本(為剔除公司回購賬户股份後的總股本)的0.3278%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.